MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Key facts
- Where
- Detroit, Egyesült ÁllamokSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Forrás: NCT07928154: ki vehet részt
Where in Egyesült Államok
- Karmanos Cancer InstituteDetroit, Egyesült ÁllamokNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Barbara Ann Karmanos Cancer Institute
- Trial code
- NCT07928154
- Record updated
- 2026. november 10.
- Original description
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effectsRead full original descriptionShow less
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
Inclusion: Patients-; 18-70 Years of age; have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer; about to initiate chemotherapy using one of the regimens listed in the protocol; be able to speak, read, and write English; willing and able to provide consent; have access to a stable internet connection; Providers:; being a practicing oncologist; treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app; provide consent for the study.
Exclusion: Patients-; cognitive or perceptual disturbances that prevent completing study measures Provider-; None.